Drugs / betaxolol

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) BETOPTIC S — 2007-06-08 fda.gov ↗
Approved US (FDA) BETOPTIC — 1985-08-30 fda.gov ↗

Trials 5

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01660620 Apr → Nov 2011 — Smith-Kettlewell Eye Research Institute Completed No outcome recorded
Phase 32 trials
Phase 3 NCT00061542 Jan 2003 → Nov 2006 glaucoma, ocular hypertension Alcon Research Completed No outcome recorded
Phase 3 NCT00000132 Oct 1992 → ? open-angle glaucoma National Eye Institute (NEI) Unknown No outcome recorded
Phase 42 trials
Phase 4 NCT05585125 Feb 2024 → Jul 2026 overdue diastolic heart failure Weill Medical College of Cornell University Enrolling by invitation No outcome recorded
Phase 4 NCT05019027 Jan 2024 → Mar 2026 overdue amyloidosis, heart disorder Weill Medical College of Cornell University Enrolling by invitation No outcome recorded
Comparator or background therapy4 trials
Phase 3 NCT02617459 Comparator Jan 2019 → Jul 2021 ocular hypertension, open-angle glaucoma Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. Completed No outcome recorded
Phase 4 NCT04757584 Comparator Apr 2021 → Apr 2023 diastolic heart failure Weill Medical College of Cornell University Completed No outcome recorded
Phase 4 NCT04767061 Comparator Apr 2021 → Apr 2022 diastolic heart failure Weill Medical College of Cornell University Completed No outcome recorded
— NCT00684489 Comparator Sep 2003 → Mar 2005 essential hypertension Medical University of South Carolina Completed No outcome recorded

Evidence & citations 19 cited values

Every value below carries the sentence it was read from. 12 sources stand behind the page.

FieldValueCited text
Known as betaxolol “Other names: acebutolol, atenolol, betaxolol, bisoprolol, carvedilol, labetalol, metoprolol, metoprolol succinate, metoprolol tartrate, nadolol, nebivolol, propranolol,...” NCT05585125 ↗
8

“Other Names: * acebutolol * atenolol * betaxolol * bisoprolol * carvedilol * labetalol * metoprolol succinate * metoprolol tartrate * nadolol * nebivolol * penbutolol *...” NCT05019027 ↗

“spironolactone, atenolol, betaxolol, bisoprolol, metoprolol, nadolol” NCT00684489 ↗

“betaxolol” NCT04767061 ↗

“betaxolol” NCT04757584 ↗

NCT00061542 ↗

NCT00000132 ↗

NCT01660620 ↗

NCT02617459 ↗

Known as ALO 1401-02 ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as ALO-140102 FREE BASE ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as betaxolol HCl “BETOPTIC S (betaxolol HCl)” NCT00061542 ↗
Known as betaxolol hydrochloride “betaxolol hydrochloride ophthalmic suspension 0.25% (betaxolol)” PMID 19683191 ↗ Aug 2009
Known as Betaxolol hydrochloride component of betoptic pilo ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as Betaxolol hydrochloride component of kerledex ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as Betoptic ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as BETOPTIC S “BETOPTIC S (betaxolol HCl)” NCT00061542 ↗
Known as Betoptic susp ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as Kerledex ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as Kerlone ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as NSC-760048 ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as SL 75.212-10 ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Known as SL-7521210 FREE BASE ChEMBL registry synonym — accepted as the source's own label CHEMBL423 ↗
Action Inhibit “Beta-1 adrenergic receptor antagonist” CHEMBL423 ↗
Modality Small molecule — CHEMBL423 ↗
Route Topical “topical betaxolol hydrochloride” PMID 21843876 ↗ Aug 2011
Target ADRB1 “Beta-1 adrenergic receptor antagonist” CHEMBL423 ↗